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Dual-chamber ICD implantation via a persistent 
left superior vena cava — use of an innominate 
vein for the placement of a right ventricular 
cardioverter-defibrillator lead implantation
Implantacja dwujamowego kardiowertera-defibrylatora serca przez przetrwałą  
żyłę główną górną — wykorzystanie żyły bezimiennej do implantacji elektrody 
prawokomorowej kardiowerterowo-defibrylującej
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A 46-year-old male was referred for dual-chamber implantable cardioverter-defibrillator (ICD) implantation due to ischaemic cardio-
myopathy. His medical history was notable for an intermittent third-degree atrioventricular block. During the procedure a persistent left 
superior vena cava (PLSVC) was detected. After several attempts we succeeded in placing the shock lead (St. Jude Durata) via cephalic 
vein venesection, then through the innominate vein (IV) and right superior vena cava into the right ventricle. The atrial lead, a Medtronic 
5076, could not be inserted via the same route (Fig. 1A). Venography revealed lack of contrast filling in IV (Fig. 1B). Despite the lack of 
lumen inside the IV the hydrophilic guidewire was advanced into the right atrium (Fig. 1C); however, subsequent venography revealed 
a small dissection of the vein (Fig. 1D, E). Finally, the atrial lead was implanted through the PLSVC (Fig. 1F). The procedure remained 
uneventful thereafter. In both chambers the optimal electrical parameters were obtained. Chest X-ray confirmed the position of the leads 
(Fig. 2). Angio-computed tomography performed in order to exclude bleeding from IV showed a complete lack of contrast flow through IV,  
which was totally filled by the defibrillator lead (Fig. 3). Evaluation at 18-month follow-up in an outpatient clinic demonstrated that  
the patient was in good condition and both pacemaker leads had stable electrical parameters. In the presented case we could have 
implanted both leads via PLSVC. However, implantation of a stiff ICD lead through the PLSVC with a typical ‘figure of alpha (a)’ con-
figuration in the right atrium can result in deterioration of tricuspid valve function and predispose to lead failure in the long-term. The 
alternative approach would be implantation of the whole ICD system on the right side of the chest. In such cases, however, a second 
surgical intervention and dual-coil ICD lead would be necessary. The use of IV for implantation of an ICD lead allowed us to avoid 
problems related to the loop in the right atrium and place the ICD generator on the left side of the chest connected to a single-coil lead. 
Implantation of a dual-chamber ICD system in patients with rare venous anatomical anomalies is technically difficult, if not impossible. 
In cases of visualisation of left IV on intraoperative venography, it may be used for the placement of a lead. Interestingly, in patients with 
co-existing PLSVC IV usually has a small calibre, and it is challenging to place more than one lead through its lumen. The presented case 
draws attention to the difficulties that are encountered during implantation of an ICD in patients with PLSVC. PLSVC is a rare congenital 
venous anomaly that impedes placement of various cardiac implantable electronic devices. It is reported to occur in 0.3–2.0% of the 
general population. The routine use of pre-operative venography enables the operator to choose the optimal procedural strategy in 
patients with asymptomatic congenital venous anomaly.
Figure 1. A–F. Subsequent stages of dual-
-chamber implantable cardioverter-defibrillator 
implantation
Figure 3. Angio-computed 
tomography revealing lack of 
contrast flow through IV
Figure 2. Chest X-ray after implan-
tation of dual-chamber implantable 
cardioverter-defibrillator
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